DR REDDYS LABORATORIES LTD (RDY) Form 6-K — Sep 14, 2026

$RDYForm 6-KFiled Sep 14, 2026, 6:35 AM ET0001575872-26-000646Original filing

Dr. Reddy's Laboratories disclosed that the USFDA completed a records assessment under Section 704(a)(4) of the Federal Food, Drug, and Cosmetic Act at its API manufacturing facility, Industrias Químicas Falcón de México (Dr. Reddy's Mexico), in Jiutepec, Morelos, Mexico. The assessment ran from July 17, 2026 to September 8, 2026.

Key figures

Fda observations: 2
Assessment period: July 17, 2026 to September 8, 2026

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.